TITLE:
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

CONDITION:
Age-Related Macular Degeneration

INTERVENTION:
AG-013,958

SUMMARY:

      AG-013,958 is being studied to treat patients with Age-Related Macular Degeneration. A total
      of 144 subjects may be enrolled in the trial. Subjects will be male or female at least 55
      years of age with "wet" age-related macular degeneration.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 55 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Male and/or female subjects >=55 years of age

          -  Subfoveal choroidal neovascularization complicating age-related macular degeneration

          -  Subjects who are informed of, and willing and able to comply with, the
             investigational nature of the study and are able to provide written informed consent
             in accordance with institutional and regulatory guidelines

        Exclusion Criteria:

          -  Other serious ocular diseases or conditions, including diabetic retinopathy and
             glaucoma, that are likely to compromise visual acuity within 1 year
      
